RxDoctor Payments DataLook up a doctor →

Glatiramer Acetate: payments to doctors

Payments that named Glatiramer Acetate as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$98K
Providers
135
Transactions
233
Average per transaction
$421

The per-transaction average — $421 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 135 providers the average total is $727, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Mylan Institutional Inc.$49,18750.1%
Mylan Specialty L.p.$17,58917.9%
Mylan Inc.$12,76913.0%
Viatris Specialty LLC$10,66010.9%
Mylan Pharmaceuticals Inc.$7,9008.1%
← All drugs & devices